Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.58 Delayed Data As of Mar 31 |  -0.01 / -0.39%Today’s Change | 1.41 Today|||52-Week Range 3.35 | +38.71% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -13.2M | -22.4M | -64.8M | -52.0M | |
| Depreciation | 11.8K | 56.5K | 80.3K | 141.7K | ||
| Total Other Cash Flow | 5.9M | 3.6M | 32.3M | 7.1M | ||
| Funds From Operations | -7.3M | -18.7M | -32.5M | -44.8M | ||
| Funds From/For Other Operating Expenses | -1.8M | -914.4K | -996.9K | 787.9K | ||
| Net Cash Flow - Operating Activities | -5.5M | -17.8M | -31.5M | -45.6M | ||
| Investing | Increase In Investments | 0.00 | 0.00 | 0.00 | -50.0M | |
| Decrease In Investments | 0.00 | 0.00 | 0.00 | 45.0M | ||
| Capital Expenditures | -32.1K | -30.4K | -38.9K | -33.9K | ||
| Net Cash Flow Investing | -56.3K | -189.0K | -47.4K | -5.4M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | -13.7K | 0.00 | 0.00 | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 70.6M | 0.00 | 69.8M | 286.1K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 3.1M | 0.00 | ||
| Net Cash Flow - Financing | 70.6M | -13.7K | 66.7M | 286.1K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 65.1M | -18.0M | 35.2M | -50.6M | ||
